Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vizel (Kazan, Russian Federation), I. Vizel (Kazan; Moscow, Russian Federation), G. Shakirova (Kazan, Russian Federation), P. Kolesnilkov (Kazan, Russian Federation). Splenomegalia in patients with pulmonary sarcoidosis.. 1379

Member's Comments

No comment yet.

Related content which might interest you: The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Central European idiopathic pulmonary fibrosis (IPF) patients survey Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Charectristics of pulmonary cavitary lesion in patients with pulmonary TB Source: Eur Respir J 2004; 24: Suppl. 48, 284s Year: 2004 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2004; 24: Suppl. 48, 199s Year: 2004 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2003; 22: Suppl. 45, 247s Year: 2003 Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006 Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Pulmonary hypertension is common in end-stage sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Are pulmonary and extra-pulmonary features affected in patients with Beta-thalassemia? Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 Autoreactivity in patients with respiratory sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension? Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020 Year: 2020 A study of pulmonary parenchymal and vascular disease in patients with familial Mediterranean fever (fmf) Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Neutrophil-rich inflammation in induced sputum of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009